Clarinex (Deloratadine) Tablets, Schering NDA 21-297 2/8/02 2/19/02 2/19/02 4/30/02 Clarinex (Deloratadine) Tablets, Schering NDA 21-363 2/8/02 2/19/02 2/19/02 4/30/02 Clarinex Indications: 21-297 Chronic Idiopathic Uritcaria & 21-363 Perennial Rhinitis. Clarinex RediTabs (Deloratadine) Orally Disintegrating Tablets, Schering NDA 21-312/S2 2/6/03 2/12/03 Clarinex RediTabs (Deloratadine) Orally Disintegrating Tablets, Schering NDA 21-312 6/26/02 7/2/02 7/1/02 7/8/03 Clarinex (Deloratadine) Tablets, Schering NDA 21-165/S1 2/8/02 4/16/02 2/20/03 7/8/03 Clarinex (Deloratadine) Tablets, 5 mg, Schering NDA 21-165 Clarinex & RediTabs (Deloratadine) Tablets & Orally Disintegrating Tablets, Schering Corporation

For the most up-to-date approval information, please locate this API using the drug index.